Pfizer and Takeda deals put spotlight back on value-based pricing programs
Over the last decade, value-based reimbursement models have garnered a mountain of interest, but challenges in building a data infrastructure that can identify outcome metrics and logistics to dispense payments have largely relegated these models to anecdotal status. Recent deals by Pfizer and Takeda may indicate a step forward. Precision’s Ryan Cox weighs in on the evolving state of value based reimbursement models.
Miss any of our Recent Precision Value & Health Events? Check out our December Events Calendar
Miss any of our recent Precision Value & Health events? Check out our monthly marketing activities calendar to catch up on-demand, and stay ahead of upcoming dates!
Treating Mental Health: Pay Now or Pay More Later
Mental health conditions, including depression and anxiety, have skyrocketed over the past two years during the pandemic. This mental health epidemic has sparked innovation among forward-looking leaders in the pharmaceutical and healthcare industries. Precision’s Cynthia Miller and Maureen Hennessey look at some of the newer innovations on the horizon as well as some of the policy changes in play that will accelerate transformation.
From Cold Prospect to Healthy Relationship w/ Mike Chambers
Listen as PRECISIONvalue’s Mike Chambers sits down with Ethan Beute, host of The Customer Experience Podcast, to discuss why relationship and responsiveness are at the center of customer experience, as well as other key insights regarding sales strategies.
Upcoming Webinar: Cost-Effectiveness Analysis with R? A Discussion
Are you involved in preparing health technology assessment (HTA) submissions and in early health economic modeling as part of drug development decision-making? You won’t want to miss our new webinar, “Cost-Effectiveness Analysis with R? A Discussion.” Learn about the pros and cons of R versus Excel in preparing HTA submissions, and the acceptability of R by HTA agencies Wednesday, December 15 at 12:00PM EST.
Virtual ISPOR Europe 2021
Attending Virtual ISPOR EU 2021 30 November-3 December? PRECISIONadvisors and PRECISIONheor will be attending with 18 insightful posters, panels, presentations and workshops!
(more…)
On-Demand Webinar: Oral Oncolytics and Oncology Care Transformation
PRECISIONvalue’s 2021 Care Management Survey found that Oncology was the top condition for which patients were referred for Care Management, and tools, resources and programs for supporting medication adherence were the top type of support that respondents would like to receive from pharmaceutical manufacturers.
LTEN 2021: Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D
Are you attending LTEN 2021, November 8-11? Don’t miss the workshop “Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D” on Wednesday, 11/10 at 3:30pm MST | 5:30pm EDT in the Cottonwood 6 room! (more…)
On-Demand Interview: The Science Advisory Board – Precision ADVANCE Aims to Improve Patient Access to Cell and Gene Therapy
Anshul Mangal (President of Project Farma and Precision ADVANCE) and Phil Cyr (SVP, Customer Solutions at Precision Value & Health) sat down with Samantha Black (Editor in Chief at ScienceBoard) to discuss how Precision ADVANCE is driving innovation in the advanced therapy sector by improving patient access through interconnected services across the drug development spectrum.
(more…)
COVID-19 and Diabetes: Strategies to Catch Up
While new diagnoses of diabetes in adults have slowed in recent years, the pandemic may reverse this trend. Physicians, payers, and pharmaceutical companies all can play a part in mitigating the long-term effects on persons with diabetes. Precision’s Cynthia Miller details how these stakeholders can collaborate to mitigate future damage. (more…)